Tarlatamab Rechallenge After Grade 3 Cytokine Release Syndrome Leading to Tumor Regression in Two Weeks and Reopening of a Collapsed Lung: A Case Report.
Saved in:
| Title: | Tarlatamab Rechallenge After Grade 3 Cytokine Release Syndrome Leading to Tumor Regression in Two Weeks and Reopening of a Collapsed Lung: A Case Report. |
|---|---|
| Authors: | Schieber T; The University of Kansas Cancer Center, Westwood, KS. Electronic address: t96249@kumc.edu., Neupane P; The University of Kansas Cancer Center, Westwood, KS., Li H; The University of Kansas Cancer Center, Westwood, KS., Huang C; The University of Kansas Cancer Center, Westwood, KS., Zhang J; The University of Kansas Cancer Center, Westwood, KS. |
| Source: | Clinical lung cancer [Clin Lung Cancer] 2025 Mar; Vol. 26 (2), pp. e126-e129. Date of Electronic Publication: 2024 Dec 16. |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| ISSN: | 1938-0690 |
|---|---|
| DOI: | 10.1016/j.cllc.2024.12.005 |
